Interstitial lung diseases (IDLs) are a diverse group of pulmonary disorders characterized
by disruption of the lung tissue resulting in pulmonary fibrosis and progressive difficulty
breathing. The diagnosis of specific IDLs is not straightforward. There
is often doubt over the diagnosis such that recommendations have been made to utilize
multidisciplinary discussions between specialists who are experienced in the diagnosis
The purpose of this study is to provide lung tissue samples for the optimization of a genomic test that will provide a range of diagnostic and prognostic information about IDLs.
Location: Peninsula/South Bay
Contact: Veronica Luna LunaV1@sutterhealth.org
March 01, 2016
June 30, 2018
Investigator(s): Ellis C. Dillon, Ph.D.
Lung Function Improvement After Bronchoscopic Lung Volume Reduction With Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE)
Investigator(s): Ganesh Krishna, M.D.
Investigator(s): Sandra Wilson, Ph.D.